Martin Shkreli: Difference between revisions

Line 7:

|goals = Raising prices on pharmaceutical drugs. (Succeeded)

|type of villain = Corrupt businessman

|origin = Brooklyn, New York City, New York, USA|hobby = Business, video games, etc.|crimes = Securities fraud}}'''Martin Shkreli''' (March 17<sup>th</sup>, 1983 -) is a businessman and hedge fund manager, who founded Elea Capital, MSMB Capital Management, and MSMB Healthcare. Shkreli is also the founder and former CEO of Turing Pharmaceuticals. In September 2015, Shkreli received widespread ~~criticism~~ for raising the prices on anti-parasitic drug Daraphrim from $13.50 to $750 a pill. The move was criticized by numerous organizations, and candidates of the 2016 presidential election, Hillary Clinton, Bernie Sanders, and Donald Trump.

|origin = Brooklyn, New York City, New York, USA|hobby = Business, video games, etc.|crimes = Securities fraud}}'''Martin Shkreli''' (March 17<sup>th</sup>, 1983 -) is a businessman and hedge fund manager, who founded Elea Capital, MSMB Capital Management, and MSMB Healthcare. Shkreli is also the founder and former CEO of Turing Pharmaceuticals. In September 2015, Shkreli received widespread scrutiny for raising the prices on anti-parasitic drug Daraphrim from $13.50 to $750 a pill. The move was criticized by numerous organizations, and candidates of the 2016 presidential election, Hillary Clinton, Bernie Sanders, and Donald Trump.

==Trial==

@@ Line 7: / Line 7: @@
 |goals = Raising prices on pharmaceutical drugs. (Succeeded)
 |type of villain = Corrupt businessman
-|origin = Brooklyn, New York City, New York, USA|hobby = Business, video games, etc.|crimes = Securities fraud}}'''Martin Shkreli''' (March 17<sup>th</sup>, 1983 -) is a businessman and hedge fund manager, who founded Elea Capital, MSMB Capital Management, and MSMB Healthcare. Shkreli is also the founder and former CEO of Turing Pharmaceuticals. In September 2015, Shkreli received widespread criticism for raising the prices on anti-parasitic drug Daraphrim from $13.50 to $750 a pill. The move was criticized by numerous organizations, and candidates of the 2016 presidential election, Hillary Clinton, Bernie Sanders, and Donald Trump.
+|origin = Brooklyn, New York City, New York, USA|hobby = Business, video games, etc.|crimes = Securities fraud}}'''Martin Shkreli''' (March 17<sup>th</sup>, 1983 -) is a businessman and hedge fund manager, who founded Elea Capital, MSMB Capital Management, and MSMB Healthcare. Shkreli is also the founder and former CEO of Turing Pharmaceuticals. In September 2015, Shkreli received widespread scrutiny for raising the prices on anti-parasitic drug Daraphrim from $13.50 to $750 a pill. The move was criticized by numerous organizations, and candidates of the 2016 presidential election, Hillary Clinton, Bernie Sanders, and Donald Trump.
 ==Trial==